Health PR
Arriving at Spectrum in New York City – GLOBALHealthPR Exchange 2016
Arriving in New York City on Sunday (September 25, 2016), I was immediately taken aback by the sheer size and volume of the place. It’s a phenomenal city to behold. I was met and escorted around Spectrum’s sleek, new office in Battery Park, close to the southernmost tip of Manhattan Island, on floor 26 of…
Read MoreDay 1 of Mark Henderson’s GLOBALHealthPR Exchange at Spectrum, Washington, D.C.
Since arriving in Washington DC as part of the GLOBALHealthPR Professional Exchange Program, I’ve been privileged to witness a lot of American history, from Capitol Hill (the seat of the United States Congress and legislative branch of the US Federal Government), to The White House (the official residence and principal workplace of the President of…
Read MoreVIVA! clinches Highly Commended in Health Organisations category at QLD PRIA Golden Target Awards
If you’ve ever submitted a state-of-the-art PR campaign into an industry competition, you would fully comprehend the process involved. But the effort can certainly pay off. The 2016 PR industry awards season kicked-off last Friday, September 16 in Brisbane with the Public Relations Institute of Australia’s (PRIA) 40th Golden Target Awards (GTAs). PRIA’s Queensland State…
Read MoreAustralia’s only locally manufactured QIV now TGA approved – August 2, 2016
Australia’s only locally manufactured, quadrivalent seasonal influenza vaccine (QIV) received Therapeutic Goods Administration (TGA) approval on July 15, 2016. Afluria Quad™, Seqirus’ four-strain, inactivated seasonal influenza vaccine, is indicated for people aged 18 years and older.1 The new quadrivalent vaccine will replace the company’s trivalent vaccine (TIV), Fluvax® for the 2017 flu season. Manufactured by…
Read MoreResearchers develop vaccine targeting abnormal proteins that trigger Alzheimer’s – July 16, 2016
A vaccine to prevent the onset of Alzheimer’s disease is a step closer following a breakthrough development that successfully targets the abnormal proteins that trigger the disease. In what is being hailed as the first vaccine of its kind, Flinders University, Adelaide and US researchers contend the vaccine could be used to prevent Alzheimer’s, and…
Read More